BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16430889)

  • 1. Heterogeneous PrPC metabolism in skeletal muscle cells.
    Massimino ML; Ferrari J; Sorgato MC; Bertoli A
    FEBS Lett; 2006 Feb; 580(3):878-84. PubMed ID: 16430889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
    Benvegnù S; Poggiolini I; Legname G
    J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine.
    Albanese V; Lawson VA; Hill AF; Cappai R; Di Guardo G; Staikopoulos V; Thacker M; Furness JB; Chiocchetti R
    Auton Neurosci; 2008 Jun; 140(1-2):17-23. PubMed ID: 18358791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
    Sorgato MC; Bertoli A
    Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
    Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
    Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell culture models of transmissible spongiform encephalopathies.
    Béranger F; Mangé A; Solassol J; Lehmann S
    Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired exercise capacity, but unaltered mitochondrial respiration in skeletal or cardiac muscle of mice lacking cellular prion protein.
    Nico PB; Lobão-Soares B; Landemberger MC; Marques W; Tasca CI; de Mello CF; Walz R; Carlotti CG; Brentani RR; Sakamoto AC; Bianchin MM
    Neurosci Lett; 2005 Nov; 388(1):21-6. PubMed ID: 16039050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to detect prion protein (PrPres) by immunohistochemistry in striated muscle tissues of animals experimentally inoculated with agents of transmissible spongiform encephalopathy.
    Hamir AN; Miller JM; Cutlip RC
    Vet Pathol; 2004 Jan; 41(1):78-81. PubMed ID: 14715973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy.
    Zanusso G; Vattemi G; Ferrari S; Tabaton M; Pecini E; Cavallaro T; Tomelleri G; Filosto M; Tonin P; Nardelli E; Rizzuto N; Monaco S
    Brain Pathol; 2001 Apr; 11(2):182-9. PubMed ID: 11303793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurochemical nature of PrP(c)-containing cells in the rat brain.
    Moleres FJ; Velayos JL
    Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.
    Nicolas O; Gavín R; del Río JA
    Brain Res Rev; 2009 Oct; 61(2):170-84. PubMed ID: 19523487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of proteins with high affinity for refolded and native PrPC.
    Petrakis S; Sklaviadis T
    Proteomics; 2006 Dec; 6(24):6476-84. PubMed ID: 17111435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.